Jiangsu gdk Biotechnology Co., Ltd. (688670.SS)
CNY 12.29
(-0.89%)
CNY 12.29
(-0.89%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 | 186.4 Million CNY | 16.82% |
| 2022 | 189.71 Million CNY | -1.2% |
| 2021 | 192.01 Million CNY | -30.93% |
| 2020 | 277.98 Million CNY | 239.93% |
| 2019 | 81.77 Million CNY | 110.9% |
| 2018 | 38.77 Million CNY | -12.35% |
| 2017 | 44.23 Million CNY | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 Q2 | 16.81 Million CNY | -49.42% |
| 2024 Q1 | 33.25 Million CNY | -60.45% |
| 2024 Q3 | 33.53 Million CNY | 122.78% |
| 2023 Q3 | 31.41 Million CNY | 21.47% |
| 2023 Q1 | 57.45 Million CNY | 3.28% |
| 2023 FY | 221.63 Million CNY | 16.82% |
| 2023 Q2 | 25.85 Million CNY | -54.99% |
| 2023 Q4 | 84.08 Million CNY | 167.68% |
| 2022 Q3 | 88.01 Million CNY | 236.18% |
| 2022 Q2 | 26.18 Million CNY | 31.63% |
| 2022 Q1 | 19.89 Million CNY | -16.11% |
| 2022 FY | 189.71 Million CNY | -1.2% |
| 2022 Q4 | 55.62 Million CNY | -36.8% |
| 2021 Q4 | 23.71 Million CNY | -80.0% |
| 2021 FY | 192.01 Million CNY | -30.93% |
| 2021 Q3 | 118.55 Million CNY | 472.56% |
| 2021 Q1 | 29.04 Million CNY | -78.85% |
| 2021 Q2 | 20.7 Million CNY | -28.72% |
| 2020 FY | 277.98 Million CNY | 239.93% |
| 2020 Q2 | 46.22 Million CNY | 82.29% |
| 2020 Q1 | 25.36 Million CNY | 0.0% |
| 2020 Q3 | 69.04 Million CNY | 49.35% |
| 2020 Q4 | 137.35 Million CNY | 98.94% |
| 2019 FY | 81.77 Million CNY | 110.9% |
| 2018 FY | 38.77 Million CNY | -12.35% |
| 2017 FY | 44.23 Million CNY | 0.0% |